pirfenidone has been researched along with candesartan in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Forslund, T; Iversen, BM; Leh, S; Margolin, SB; Vaagnes, Ø | 1 |
AlQudah, M; Czubryt, MP; Hale, TM | 1 |
1 review(s) available for pirfenidone and candesartan
Article | Year |
---|---|
Targeting the renin-angiotensin-aldosterone system in fibrosis.
Topics: Amides; Angiotensins; Animals; Benzimidazoles; Biphenyl Compounds; Extracellular Matrix; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Fumarates; Gene Expression Regulation; Humans; Kidney; Liver; Molecular Targeted Therapy; Myocardium; Pyridones; Renin-Angiotensin System; Signal Transduction; Skin; Tetrazoles; Transforming Growth Factor beta | 2020 |
1 other study(ies) available for pirfenidone and candesartan
Article | Year |
---|---|
Pirfenidone and candesartan ameliorate morphological damage in mild chronic anti-GBM nephritis in rats.
Topics: Analysis of Variance; Animals; Antibodies; Autoantibodies; Base Sequence; Benzimidazoles; Biopsy, Needle; Biphenyl Compounds; Blood Chemical Analysis; Blood Pressure Determination; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Glomerulonephritis; Immunohistochemistry; Kidney Function Tests; Male; Molecular Sequence Data; Probability; Pyridones; Random Allocation; Rats; Rats, Wistar; Reference Values; Renal Circulation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensitivity and Specificity; Statistics, Nonparametric; Tetrazoles | 2005 |